chr4-143514090-G-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 1P and 10B. PP2BP4_StrongBP6_ModerateBS2
The NM_003601.4(SMARCA5):c.166G>T(p.Ala56Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000568 in 1,550,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_003601.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA5 | NM_003601.4 | c.166G>T | p.Ala56Ser | missense_variant | 1/24 | ENST00000283131.4 | NP_003592.3 | |
SMARCA5 | XM_047416323.1 | c.166G>T | p.Ala56Ser | missense_variant | 1/14 | XP_047272279.1 | ||
SMARCA5-AS1 | NR_104027.1 | n.529C>A | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA5 | ENST00000283131.4 | c.166G>T | p.Ala56Ser | missense_variant | 1/24 | 1 | NM_003601.4 | ENSP00000283131.3 | ||
SMARCA5-AS1 | ENST00000500800.2 | n.327C>A | non_coding_transcript_exon_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000129 AC: 2AN: 154748Hom.: 0 AF XY: 0.0000115 AC XY: 1AN XY: 86810
GnomAD4 exome AF: 0.0000594 AC: 83AN: 1397964Hom.: 0 Cov.: 31 AF XY: 0.0000622 AC XY: 43AN XY: 691546
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74356
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at